Market Place
Sourcing Support
Alkem`s Generics Riluzole Receives Approval in US
22 Aug 2024 //
FDA
Enforcement Report - Week of November 29, 2023
29 Nov 2023 //
FDA
MediciNova Receives Allowance for Patent Covering the Combination of MN-166
10 Oct 2023 //
GLOBENEWSWIRE
Aquestive Tx and Haisco Enter Licensing, Supply Agreement for Riluzole Oral Film
03 Mar 2022 //
GLOBENEWSWIRE
Repurposed ALS drug shows promise in mouse model of rare childhood genetic
19 Nov 2021 //
NIH
Mitsubishi Tanabe Pharma Announces EXSERVAN is Now Available in the U.S.
01 Jul 2021 //
PRESS RELEASE
Mitsubishi Tanabe Pharma America Announces EXSERVAN™ Now Available in the U.S
30 Jun 2021 //
PR NEWSWIRE
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce
21 Jan 2021 //
PRNEWSWIRE
Standard Chem`s Generic Riluzole Receives Approval in US
12 Dec 2019 //
FDA
Aquestive Therapeutics Nabs Approval for Sublingual Formulation of ALS Drug
25 Nov 2019 //
BIO SPACE
Aquestive Therapeutics Licenses Riluzole Oral Film to Zambon for Development
13 Nov 2019 //
GLOBENEWSWIRE
Biohaven suckerpunched by CRL tied to Apotex warning letter
22 Jul 2019 //
FIERCE PHARMA
Aquestive’s oral film ALS medication approved by FDA
23 Apr 2019 //
IN-PHARMANECHNOLOGIST
Daito Pharms` Generic Riluzole Receives Approval in US
20 Oct 2018 //
FDA
Summit`s $12m lifeline, Biohaven`s speech anxiety pill
16 Aug 2018 //
PMLIVE
Orion takes repurposed heart drug into phase 3 for ALS
06 Jul 2018 //
FIERCE BIOTECH
Apotex Research Private Limited On FDA Import Alert List
13 Apr 2018 //
FDA
Aquestive Receives U.S. FDA Orphan Drug Designation for Riluzole
31 Jan 2018 //
PR NEWSWIRE
US FDA clears Biohaven IND application for sublingual BHV-0223
01 Nov 2017 //
PHARMABIZ
AI-Based Personalized Drug Discovery Platform Launched
01 Jun 2017 //
SCICASTS
MonoSol Rx Appoints John T. Maxwell as Chief Financial Officer
25 Jan 2017 //
GLOBENEWSWIRE
Biohaven receives USFDA orphan drug status for BHV-0223
09 Dec 2016 //
PHARMABIZ
AB Science jumps 40% as optimism trumps skepticism in wake of PhIII ALS data
07 Apr 2016 //
FIERCE BIOTECH
Intentional Misrepresentation Of Study Data at Alkem Laboratories in India
05 Apr 2016 //
EMA
New `nectar-like` oral formulation for vital ALS drug
21 Dec 2015 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.